NCT00797316
- Conditions
- Cardiovascular Diseases, Glucose Metabolism Disorders, Hyperinsulinism, +6 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
Clinical trial condition
Hyperinsulinism
Explore clinical trials studying Hyperinsulinism. Study availability and eligibility vary by location and protocol.
3,690 public trials
358 recruiting studies
Hyperinsulinism trial results
NCT00991107
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +9 more
- Locations
-
- Clinical Site Baton Rouge, Louisiana, United States
NCT00046267
- Conditions
- Blood-Borne Infections, Communicable Diseases, Diabetes Mellitus, +23 more
- Locations
-
- UCLA School of Medicine Los Angeles, California, United States
- Univ of California, San Diego Antirviral Research San Diego, California, United States
- San Mateo County AIDS Program Stanford, California, United States
- Stanford Univ Stanford, California, United States
NCT00742456
- Conditions
- Body Weight, Cardiovascular Diseases, Glucose Metabolism Disorders, +12 more
- Locations
-
- University Hospital Maastricht Maastricht, Netherlands
NCT01133561
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +7 more
- Locations
-
- Dermatology department of cairo university faculty of medicine Cairo, Egypt
NCT01164423
- Conditions
- Critical Illness, Disease Attributes, Glucose Metabolism Disorders, +6 more
- Locations
-
- Medizinische Universität Graz, Department of Internal Medicine Graz, Austria
NCT00843232
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, São Paulo, Brazil
NCT00560469
- Conditions
- Adipocyte Differentiation, Glucose Metabolism Disorders, Hyperinsulinism, +7 more
- Locations
-
- Fletcher Allen Health Care South Burlington, Vermont, United States
NCT01154244
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- GSK Investigational Site Bucheon-si, South Korea
- GSK Investigational Site Seoul, South Korea
NCT01020617
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +12 more
- Locations
-
- Copenhagen University Frederiksberg, Denmark